Wikidata

(Q33393155)

English

Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy

scientific article

In more languages

Statements

title
Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
21135284
retrieved
26 July 2017
author name string
Robert Jotte
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
21135284
retrieved
26 July 2017
Paul Conkling
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
21135284
retrieved
26 July 2017
Craig Reynolds
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
21135284
retrieved
26 July 2017
Matthew D Galsky
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
21135284
retrieved
26 July 2017
Leonard Klein
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
21135284
retrieved
26 July 2017
James F Fitzgibbons
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
21135284
retrieved
26 July 2017
Richard McNally
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
21135284
retrieved
26 July 2017
Markus F Renschler
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
21135284
retrieved
26 July 2017
Jennifer W Oliver
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
21135284
retrieved
26 July 2017
publication date
6 December 2010
1 reference
stated in
Europe PubMed Central
PubMed ID
21135284
retrieved
26 July 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q33393155&oldid=1605079153"